TLH Cover Jan 24


The Lancet Haematology

Editor in Chief: Dr. Lan-Lan Smith

The global community of researchers and clinicians working in the research and treatment of haematological disease needs a source of information that is authoritative, evidence-based, and clinically relevant. The Lancet Haematology will become that source, with practice-changing research articles, expert commentary, and provocative opinion in an online-only format. The topics in this journal will be broad, reflecting the breadth of the subject matter, focusing on research that advocates change in, or illuminates, haematological clinical practice. This will include haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, transfusion medicine, and related conditions and diseases. Although there have been great leaps towards in haematological research and patient care, there is still much work to be done, and we hope you will join us in delivering better health.

Global Print Circulation
Available upon request
Avg. Global Monthly Visits
Avg. Global Monthly Unique Visitors
Avg. Global Monthly Page Views
Avg. Global eTOC Distribution
Circulation updated on 1st July, 2023, based on 12-month monthly average July 2022-June 2023, eTOC Metrics: 12 Month Average of eTOC sends - July 2022 to June 2023, Monthly average web metrics based on the period of July 2022 to June 2023

Rate Card

Find the best value for your advertising dollars

Journal Website

Find out more directly from the source

Journal Metrics

Detailed insights into the reach and penetration of this journal

Have a question or need assistance?